BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PALB2, ENSG00000083093, 79728
10 results:

  • 1. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
    AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
    Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic cancer Surveillance.
    Katona BW; Klute K; Brand RE; Everett JN; Farrell JJ; Hawthorne K; Kaul V; Kupfer SS; Paiella S; Simeone DM; Sussman DA; Zogopoulos G; Lucas AL; Kastrinos F;
    Cancer Prev Res (Phila); 2023 Jun; 16(6):343-352. PubMed ID: 37259800
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
    Ryu KH; Park S; Chun JW; Cho E; Choi J; Lee DE; Shim H; Kim YH; Han SS; Park SJ; Woo SM; Kong SY
    Cancer Res Treat; 2023 Oct; 55(4):1303-1312. PubMed ID: 37024097
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Contribution of germline palb2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan.
    Muhammad N; Sadaqat R; Naeemi H; Masood I; Hassan U; Ijaz B; Hanif F; Syed AA; Yusuf MA; Rashid MU
    HPB (Oxford); 2022 Dec; 24(12):2134-2144. PubMed ID: 36175305
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. EUS-based Pancreatic cancer Surveillance in
    Katona BW; Long JM; Ahmad NA; Attalla S; Bradbury AR; Carpenter EL; Clark DF; Constantino G; Das KK; Domchek SM; Dudzik C; Ebrahimzadeh J; Ginsberg GG; Heiman J; Kochman ML; Maxwell KN; McKenna DB; Powers J; Shah PD; Wangensteen KJ; Rustgi AK
    Cancer Prev Res (Phila); 2021 Nov; 14(11):1033-1040. PubMed ID: 34341011
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy of raman spectroscopy in the diagnosis of kidney cancer: A systematic review and meta-analysis.
    Jin H; He X; Zhou H; Zhang M; Tang Q; Lin L; Hao J; Zeng R
    Medicine (Baltimore); 2020 Jul; 99(27):e20933. PubMed ID: 32629694
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or palb2 mutation.
    Wattenberg MM; Asch D; Yu S; O'Dwyer PJ; Domchek SM; Nathanson KL; Rosen MA; Beatty GL; Siegelman ES; Reiss KA
    Br J Cancer; 2020 Feb; 122(3):333-339. PubMed ID: 31787751
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Response to olaparib in a
    Horak P; Weischenfeldt J; von Amsberg G; Beyer B; Schütte A; Uhrig S; Gieldon L; Klink B; Feuerbach L; Hübschmann D; Kreutzfeldt S; Heining C; Maier S; Hutter B; Penzel R; Schlesner M; Eils R; Sauter G; Stenzinger A; Brors B; Schröck E; Glimm H; Fröhling S; Schlomm T
    Cold Spring Harb Mol Case Stud; 2019 Apr; 5(2):. PubMed ID: 30833416
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer.
    Childs EJ; Mocci E; Campa D; Bracci PM; Gallinger S; Goggins M; Li D; Neale RE; Olson SH; Scelo G; Amundadottir LT; Bamlet WR; Bijlsma MF; Blackford A; Borges M; Brennan P; Brenner H; Bueno-de-Mesquita HB; Canzian F; Capurso G; Cavestro GM; Chaffee KG; Chanock SJ; Cleary SP; Cotterchio M; Foretova L; Fuchs C; Funel N; Gazouli M; Hassan M; Herman JM; Holcatova I; Holly EA; Hoover RN; Hung RJ; Janout V; Key TJ; Kupcinskas J; Kurtz RC; Landi S; Lu L; Malecka-Panas E; Mambrini A; Mohelnikova-Duchonova B; Neoptolemos JP; Oberg AL; Orlow I; Pasquali C; Pezzilli R; Rizzato C; Saldia A; Scarpa A; Stolzenberg-Solomon RZ; Strobel O; Tavano F; Vashist YK; Vodicka P; Wolpin BM; Yu H; Petersen GM; Risch HA; Klein AP
    Nat Genet; 2015 Aug; 47(8):911-6. PubMed ID: 26098869
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
    Grant RC; Selander I; Connor AA; Selvarajah S; Borgida A; Briollais L; Petersen GM; Lerner-Ellis J; Holter S; Gallinger S
    Gastroenterology; 2015 Mar; 148(3):556-64. PubMed ID: 25479140
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.